Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-113793
Filing Date
2016-04-08
Accepted
2016-04-08 18:17:08
Documents
1
Period of Report
2016-04-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3245
  Complete submission text file 0001209191-16-113793.txt   4574
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 830 CRESCENT CENTER DRIVE SUITE 610 FRANKLIN TN 37067
Business Address
JACOBS JOEY A (Reporting) CIK: 0001243878 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33637 | Film No.: 161563605